Regenerative nodule is a benign nodular lesion in the cirrhotic liver composed of hepatocyte clusters showing regeneration between fibrous septa. It is the most common type of nodule in cirrhosis and represents the earliest, benign step of the hepatocarcinogenesis sequence: regenerative nodule → low-grade dysplastic nodule → high-grade dysplastic nodule → early HCC → advanced HCC. Size is usually <2 cm, and they are multiple with diffuse distribution. On MRI, iso-hyperintense signal on T1-weighted images (due to copper accumulation) and hypointense signal on T2 (due to iron/siderotic pigment deposition) is the most important imaging feature. They show no arterial phase enhancement — this feature distinguishes them from dysplastic nodules and HCC. Clinically, no treatment beyond surveillance is needed, but increasing nodule number and changing signal characteristics (development of T2 hyperintensity, arterial enhancement) in the cirrhotic liver require close follow-up for suspected malignant transformation.
Age Range
40-80
Peak Age
60
Gender
Male predominant
Prevalence
Very Common
In the cirrhotic process, the cycle of chronic hepatocyte injury and regeneration leads to nodular proliferation of hepatocyte clusters between fibrous septa. These regenerative nodules largely preserve normal hepatocyte architecture — portal triads and hepatic venules are present, neovascularity has not developed. T1 hyperintensity in nodules is due to decreased copper excretion from chronic cholestasis and hepatocyte dysfunction leading to intracellular copper accumulation — the paramagnetic property of copper shortens T1 relaxation time. T2 hypointensity is due to intracellular siderotic pigment (hemosiderin/ferritin) accumulation from disturbed iron metabolism — superparamagnetic iron particles create local magnetic field inhomogeneities that accelerate T2/T2* relaxation. Blood flow in regenerative nodules maintains normal hepatic artery + portal vein distribution (predominant portal venous supply) — therefore they show no arterial phase enhancement. As hepatocarcinogenesis progresses, neoangiogenesis begins (unpaired arteries), portal triads are lost, and the nodule becomes arterially supplied — this transition defines dysplastic nodules and HCC.
Multiple nodules in the cirrhotic liver showing iso/hyperintense signal on T1 (copper) and hypointense signal on T2 (iron) with no arterial enhancement constitute the classic MRI triad for regenerative nodules. This triple combination indicates the nodule is in the benign regenerative process without neovascularity. Loss of T2 hypointensity or emergence of arterial enhancement is an alarm sign for hepatocarcinogenesis progression.
Regenerative nodules show isointense or mildly hyperintense signal compared to surrounding liver parenchyma on T1-weighted images. Hyperintensity is due to intracellular copper accumulation. Copper accumulation results from decreased hepatocyte copper excretion capacity due to chronic cholestasis. T1 signal may vary among nodules — some isointense (little copper), some markedly hyperintense (more copper). When fatty liver accompanies, signal loss on opposed-phase may be seen, but this reflects surrounding parenchymal steatosis, not the nodule.
Report Sentence
Multiple iso/hyperintense nodules in the cirrhotic liver on T1-weighted images, consistent with regenerative nodules due to intracellular copper accumulation.
Regenerative nodules show hypointense signal compared to surrounding parenchyma on T2-weighted images. This hypointensity is due to intracellular siderotic pigment (hemosiderin/ferritin) deposition. Hypointensity is more pronounced on T2* (gradient echo) sequences — susceptibility effect is amplified. 25-50% of all regenerative nodules show visible T2 hypointensity. Important caveat: development of T2 hyperintensity in a nodule should be evaluated with suspicion of malignant transformation (HCC is T2 hyperintense).
Report Sentence
Multiple hypointense nodules in the cirrhotic liver on T2-weighted images, consistent with regenerative nodules due to siderotic pigment deposition; no T2 hyperintense nodule has been identified.
Regenerative nodules show no enhancement in arterial phase — remain isodense to surrounding liver parenchyma. This reflects preserved normal portal venous supply and absence of neovascularity. They also remain isodense in portal venous and delayed phases. Generally invisible on CT — only markedly siderotic nodules may appear mildly hyperdense on non-contrast CT. Detection of arterial enhancement in a nodule indicates progression of hepatocarcinogenesis.
Report Sentence
Nodules in the cirrhotic liver show no arterial phase enhancement, remaining isodense to surrounding parenchyma; this pattern is consistent with regenerative nodules.
Regenerative nodules show markedly increased hypointensity with 'blooming' artifact on T2* (gradient echo) sequences. This finding reflects the susceptibility effect of siderotic pigment deposition. Blooming amount is proportional to iron concentration. T2* sequences are 2-3 times more sensitive than spin echo T2 for iron detection. This effect is even more pronounced on SWI. Siderotic regenerative nodules show shortened T2* values on T2* mapping (<10 ms). A nodule losing iron should be evaluated with suspicion of malignant transformation.
Report Sentence
Marked blooming artifact in siderotic nodules on T2* sequences, reflecting the susceptibility effect of iron deposition.
When gadoxetic acid is used, regenerative nodules appear isointense or mildly hypointense to surrounding parenchyma in hepatobiliary phase. Since normal hepatocyte function is preserved, gadoxetic acid uptake occurs. HCC is markedly hypointense in hepatobiliary phase (OATP expression loss). This finding is helpful in regenerative nodule-HCC differentiation.
Report Sentence
Regenerative nodules appear iso/mildly hypointense to surrounding parenchyma in hepatobiliary phase, indicating preserved gadoxetic acid uptake.
Multiple small nodular areas within the coarse echotexture of cirrhotic liver on B-mode ultrasound. Regenerative nodules are generally not distinguishable from surrounding parenchyma — seen as coarse nodular echo pattern. Large regenerative nodules (>1 cm) may be isoechoic or mildly hyperechoic. For nodules >1 cm, advanced imaging (contrast-enhanced MRI) is recommended.
Report Sentence
Coarse nodular echopattern and nodular surface contour of liver parenchyma on US, consistent with cirrhotic background.
Criteria
Regenerative nodules with marked intracellular iron deposition. Marked T2/T2* hypointensity and blooming artifact.
Distinct Features
Dramatic blooming on T2* sequences, may be mildly hyperdense on non-contrast CT. Valuable for hepatocarcinogenesis surveillance — iron loss as malignant transformation marker (nodule-in-nodule).
Criteria
Regenerative nodules with size >1 cm. Requires further evaluation due to size overlap with dysplastic nodules and HCC.
Distinct Features
Considered benign if T1 hyperintense + T2 hypointense + no enhancement pattern is maintained. Hepatobiliary phase assessment with gadoxetic acid MRI should be added. 6-month MRI follow-up recommended.
Criteria
Focal area within a regenerative nodule showing different signal characteristics — suggests development of dysplastic nodule or early HCC.
Distinct Features
T2 hyperintense focal area within T2 hypointense regenerative nodule and/or focus with arterial enhancement. May be classified as LI-RADS M or LR-4/5. Requires biopsy or short-interval (3 month) MRI follow-up.
Distinguishing Feature
Low-grade dysplastic nodule shows similar signal to regenerative nodule (T1 hyperintense, T2 hypointense) but is generally larger (1-2 cm). Reliable MRI differentiation is difficult. Practically, low-grade dysplastic nodule is also followed as benign.
Distinguishing Feature
In high-grade dysplastic nodule, T2 hypointensity may decrease (iron loss), mild arterial enhancement may begin, and hepatobiliary phase hypointensity may develop. In regenerative nodule, T2 remains hypointense, no arterial enhancement, and hepatobiliary uptake is preserved.
Distinguishing Feature
HCC shows marked arterial hyperenhancement (APHE) and washout. T2 hyperintense (regenerative nodule is hypointense). Capsule may be present. Markedly hypointense in hepatobiliary phase. Regenerative nodule lacks all these features. Classified per LI-RADS criteria.
Distinguishing Feature
Siderotic nodule is actually a subtype of regenerative nodule with marked iron deposition — not a separate diagnosis. Shows very pronounced T2/T2* hypointensity and blooming. Practically followed like regenerative nodule.
Urgency
surveillanceManagement
surveillanceBiopsy
Not NeededFollow-up
6-monthRegenerative nodules are benign lesions and do not require treatment. However, regular screening is essential due to HCC development risk in cirrhotic liver. Per AASLD/EASL guidelines, US + AFP screening every 6 months is recommended for cirrhosis patients. Changes in signal characteristics on MRI (loss of T2 hypointensity, onset of arterial enhancement, hepatobiliary phase hypointensity) are warning signs of malignant transformation requiring LI-RADS evaluation. Nodule-in-nodule pattern is an indication for biopsy or short-interval follow-up. Prognosis is determined by the stage of underlying cirrhosis (Child-Pugh/MELD).
Regenerative nodules are benign and do not require treatment. However, differentiation from dysplastic nodules and early HCC in the cirrhotic liver is critically important. Interval growth or development of arterial enhancement warrants further evaluation.